BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:30@myasthenia.org
DTSTART;TZID=America/New_York:20230921T220000
DTEND;TZID=America/New_York:20230921T233000
DTSTAMP:20241028T210311Z
URL:https://myasthenia.org/events/research-webinar-series-memgopen-an-inno
 vative-research-study-with-a-groundbreaking-digital-tool-for-myasthenia-gr
 avis-2023-09-21/
SUMMARY:Research Webinar Series: ME&MGopen\, an innovative research study w
 ith a\n        groundbreaking digital tool for Myasthenia gravis
DESCRIPTION:The Power of Medical Records in MG Research Presented by Emma T
 ouré Cuq\, International Clinical Trials Manager at Ad Scientiam Septembe
 r 21\, 2023 @ 3PM Eastern\, 12PM Pacific  ME&amp\;MGopen is a smartphone a
 pplication developed by Ad Scientiam. It features active tests to assess b
 reathing\, dysarthria (difficulty speaking)\, ptosis (eyelid drooping)\, a
 rm and leg weakness. The mobile app also includes online questionnaires re
 lated to activities of daily living\, pain\, insomnia\, quality of life an
 d depression. The ME&amp\;MGopen research study aims to better understand 
 Myasthenia Gravis in real life\, collecting data directly from the patient
 &rsquo\;s perspective with an exclusive digital tool. The study also aims 
 to collect feedback from participants to improve ME&amp\;MGopen app. Join 
 this webinar to learn more about the study objectives &amp\; design and fi
 nd out about the first insights gathered from the analysis!   Ad Scientiam
  is a young French company created in 2013\, based in Paris. Our team is c
 omposed of researchers\, data science engineers\, user experience experts\
 , interface designers\, web and mobile developers\, clinical project manag
 ers and medical innovation specialists. We work together in synergy to dev
 elop the most appropriate digital solutions in collaboration with medical 
 experts and patient associations. At the heart of Ad Scientiam&rsquo\;s pr
 oject is a conviction: continuously measuring and following the evolution 
 of severe and disabling diseases in real life is the key to better care fo
 r patients. Ad Scientiam is taking this scientific and technological bet\,
  so that today each patient can be an actor in their own health and to acc
 elerate the development of new treatments. We are committed to ensuring th
 at the medicine of tomorrow is more predictive\, preventive and individual
 ized. Their use allows Ad Scientiam to provide innovative\, easy-to-use an
 d intuitive solutions Register for This Webinar  
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/Portal
 s/0/EasyDNNNews/601/emma-webinar-headerpic-3.jpg
CATEGORIES:Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20230312T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR